This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Kimberly-Clark Increases Production Of Face Mask Products To Address Flu Epidemic-Related Needs





ROSWELL, Ga., Feb. 8, 2013 /PRNewswire/ --  With the 2012-2013 influenza season reaching epidemic levels across the U.S., Kimberly-Clark is continuing to increase production of face masks and other Personal Protective Equipment (PPE) products in response to increased customer demand from acute care facilities across the country.

(Logo: http://photos.prnewswire.com/prnh/20110928/DA76879LOGO)

The Centers for Disease Control and Prevention (CDC) reported that the flu season began earlier than usual this year and is shaping up to be more severe than in years past[1]. Kimberly-Clark, the market leader in facial protection in the U.S., has been closely monitoring CDC data and adjusting manufacturing schedules and inventory management in anticipation of continued increased demand from current customers for PPE, including face mask products.

"The health and safety of our valued customers and their patients is our most important priority," said John Amat, Vice President of Sales and Marketing, Kimberly-Clark Health Care. "Kimberly-Clark representatives are proactively reaching out to all of our current customers to assure them that with our North America-based product supply, we can continue to provide the highest quality facial protection products throughout the flu season."  

To further help customers, their patients and consumers prevent the spread of the flu, Kimberly-Clark recommends these simple prevention precautions: 

  • Get vaccinated - The CDC recommends a yearly flu vaccine as the first and most important step in protecting against this serious virus.[2]
  • Pay attention to hand hygiene - One of the best ways to help prevent the spread of the flu is to wash your hands with soap and water. If soap and water are not available, use an alcohol-based hand rub.[3]
  • Contain the germs - Cover your nose and mouth with a tissue when you cough or sneeze. This will block the spread of droplets from your mouth or nose that could contain germs.[4]

Additional tips and information for patients can be found at www.preventinfections.com.  Kimberly-Clark also offers complimentary, accredited clinical education webinars on the topic of flu via The Kimberly-Clark Knowledge Network, http://en.haiwatch.com/ClinicalEducation.aspx#5.    

Kimberly-Clark in the Healthcare Environment

Around the world, medical professionals turn to Kimberly-Clark for a wide portfolio of solutions that improve the health, hygiene and well-being of their patients and staff. As part of their healing mission, caregivers rely on Kimberly-Clark to deliver clinical solutions, hygiene & cleaning offerings, and educational resources that they can depend on to prevent, diagnose and manage a wide variety of healthcare-associated infections. This more than $1 billion global enterprise of Kimberly-Clark Corporation holds the No. 1 or No. 2 market share position in several categories, including infection control solutions, surgical solutions, pain management, hygiene solutions and digestive health. And throughout the care continuum, patients and staff alike trust Kimberly-Clark medical supplies and devices, KLEENEX tissues, KLEENEX & SCOTT skin care products and SCOTT towels for day-to-day needs. For more information, visit http://www.kchealthcare.com and http://www.kcprofessional.com



1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,096.90 -106.47 -0.58%
S&P 500 2,098.53 -9.25 -0.44%
NASDAQ 4,967.1410 -12.76 -0.26%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs